Showing results (51-60 of 237) with videos related to
Sort By:
Pageof 24
Drugs|March 11, 2000
Oral chemotherapy in the treatment of hormone-refractory prostate cancerK J Pienta, J M Kamradt, D C SmithCancer|June 8, 2001
Chemotherapy in patients with prostate specific antigen-only disease after primary therapy for prostate carcinoma: a phase II trial of oral estramustine and oral etoposideH G Munshi, K J Pienta, D C SmithSeminars in Urologic Oncology|May 20, 1999
Vitamin E, alpha- and gamma-tocopherol, and prostate cancerM A Moyad, S K Brumfield, K J PientaThe Urologic Clinics of North America|June 11, 1999
Rational use of chemotherapy. It is not just rat poisonJ M Kamradt, E A Klein, K J PientaThe Urologic Clinics of North America|June 11, 1999
Oral chemotherapy for hormone refractory prostate cancer. The University of Michigan experienceJ M Kamradt, D C Smith, K J PientaBiochemical and Biophysical Research Communications|December 5, 1995
Galectin-3 is a nuclear matrix protein which binds RNAL Wang, H Inohara, K J Pienta, et al.Anticancer Research|November 1, 1993
Pentosan inhibits angiogenesis in vitro and suppresses prostate tumor growth in vivoN M Nguyen, J E Lehr, K J PientaUrology|August 12, 1999
Use of PC-SPES, a commercially available supplement for prostate cancer, in a patient with hormone-naive diseaseM A Moyad, K J Pienta, J E MontieUrology|February 22, 2001
Different docetaxel-induced apoptotic pathways are present in prostate cancer cell lines LNCaP and PC-3H J Muenchen, P J Poncza, K J PientaAnticancer Research|January 19, 1999
The isolation and characterization of epithelial cells from canine prostateJ E Lehr, M J Pilat, K J PientaPageof 24